cabotegravir-stearoylate

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug Namecabotegravir-stearoylate
Drug Alias Namecabotegravir-stearoylate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action +[1]  N/A
TargetsHIV integrase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Nebraska Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Nebraska Medical Center
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A